Multiple Myeloma: Our Clinical Trials

Here you can find a continually updated listing of Memorial Sloan-Kettering’s current clinical trials for multiple myeloma and related hematologic disorders. To learn more about a study, choose from the list below.

Showing 16 trials
Titlesort icon Investigator
A Phase I/II Study of AT7519M with and without Bortezomib in Patients with Previously Treated Multiple Myeloma
[Protocol 10-151] 		Landau, Heather, MD
A Phase I/II Study of CDX-1401 in Patients with Cancers Known to Express NY-ESO-1
[Protocol 09-165] 		Keohan, Mary, MD
A Phase IB/IIA Study of ABT-888 in Combination with Bendamustine with or without Rituximab in Patients with Lymphoma, Multiple Myeloma, and Solid Tumors
[Protocol 10-174] 		Gerecitano, John, MD, PhD
A Phase II Study of Lenalidomide Intensification in Patients with Asymptomatic Multiple Myeloma that Has Progressed with Lenalidomide Maintenance Therapy after Autologous Stem Cell Transplantation
[Protocol 11-107] 		Hassoun, Hani, MD
A Phase II Study of Melphalan with Stem Cell Transplant and Adjuvant Bortezomib and Dexamethasone for Recently Diagnosed Untreated Systemic Light-Chain Amyloidosis
[Protocol 07-006] 		Landau, Heather, MD
A Phase II Study of TKI258 in Patients with Relapsed or Refractory Multiple Myeloma
[Protocol 10-221] 		Hassoun, Hani, MD
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders
[Protocol 10-050] 		O'Reilly, Richard, MD
A Phase III Study of Pomalidomide versus Placebo in Patients with Myeloproliferative Neoplasm-Associated Myelofibrosis Who Are Dependent on Red Blood Cell Transfusions
[Protocol 11-025] 		Heaney, Mark, MD, PhD
A Prospective Natural History Study of the Diagnosis, Treatment, and Outcomes of Children with SCID Disorders
[Protocol 10-150] 		O'Reilly, Richard, MD
A Study of Busulfan, Melphalan, Fludarabine and T-Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Followed by Post-Transplantation Donor Lymphocyte Infusions for Patients with Relapsed or High-Risk Multiple Myeloma
[Protocol 10-051] 		Koehne, Guenther, MD, PhD
A Trial of Single Autologous Transplant with or without Consolidation Therapy versus Tandem Autologous Transplant with Lenalidomide Maintenance for Patients with Multiple Myeloma
[Protocol 09-171] 		Landau, Heather, MD
Expanded Access Study to Evaluate Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma
[Protocol 11-158] 		Lendvai, Nikoletta, MD
Phase II Study of Carfilzomib in Patients with Relapsed or Refractory Multiple Myeloma
[Protocol 10-228] 		Lendvai, Nikoletta, MD
Pilot Study of Bortezomib/Dexamethasone Followed by Autologous Stem Cell Transplantation and Maintenance Bortezomib/Dexamethasone for the Initial Treatment of MIDD Associated with Multiple Myeloma and Amyloidosis
[Protocol 11-061] 		Hassoun, Hani, MD
Pilot Study of MAGE-A3 Vaccination as Consolidation Therapy for Multiple Myeloma Patients Undergoing Autologous Stem Cell Transplantation
[Protocol 10-216] 		Lendvai, Nikoletta, MD
Pilot Trial of Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant
[Protocol 11-105] 		Landau, Heather, MD
Recommended Links

Clinical Trials

Clinical trials can offer you access to a new, experimental treatment before it is available to most patients. Joining a clinical trial is also a way to make a valuable contribution toward the fight against cancer.